Transcendence of Medicine Regenerative Strategies in the Treatment for Diabetic Foot Ulcers
ISSN: 2476-2253
Journal of Cancer Diagnosis

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
  • Short Communication   
  • J Cancer Diagn 2016, Vol 1(1): 106
  • DOI: 10.4172/2476-2253.1000106

Transcendence of Medicine Regenerative Strategies in the Treatment for Diabetic Foot Ulcers

Diaz-Garcia H1 and Benítez-Arvízu G2*
1Laboratorio de Medicina Regenerativa y Estudios en Cancer, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de México, Mexico
2Banco Central de Sangre, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico
*Corresponding Author: Benítez-Arvízu G, Director of Banco Central de Sangre, Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Cuauhtemoc Avenue 300, Colony Doctores, Ciudad De Mexico, 06720, Mexico, Tel: +52 55 5729 6000, Email: [email protected], [email protected]

Received Date: Jun 16, 2016 / Accepted Date: Jul 12, 2016 / Published Date: Nov 12, 2016


The Diabetes Mellitus type 2 and one of its complications, the diabetic foot ulcer (DFU), are a great problem of public health that affects millions of people around the world. Due to its complexity, DFUs treatment and handling are expensive and complex. In addition, amputations of lower limbs and death are relatively frequent because conventional treatment cannot avoid them. In other hand, the use of growth factors, 3D scaffolds and mesenchymal stem cells, called regenerative medicine (RM), have created new perspectives about the treatment of this kind of injuries. The RM has demonstrated favorable clinical outcomes not only in the case of DFUs, so that, this new medicine area promises to become an important tool that supports or substitutes to conventional treatment in cases of tissue or organic damage caused by the different chronic and traumatic diseases.

Keywords: Diabetes foot ulcer; Mesenchymal stem cells; Regenerative medicine


Diabetes mellitus type 2 (DM2) is a great problem of world health that affects to millions of people around the world and it has been anticipated that the number of patients will be increase in the next decades [1]. Some of its complications as peripheral neuropathy and peripheral vascular disease are related to development cutaneous injures in lower limbs that are known like diabetic foot ulcers (DFUs) [2-4]. In addition, due to the generalized inflammatory state, characteristic of this disease, the healing process are affected, causing a slowly and costly recovery [2,5-11].

In spite of current treatments, a great number or people with DFUs will suffer lower limb amputation along its life [2,12], this fact becomes to DFUs as the first cause of non-traumatic amputation in world [13], and if this was not enough, the patient’s lifespan will decrease drastically within first five years after the surgery [9,14-16]. The treatment of DFUs is focus in promote the scarring of wound through different methods, for example; hydrocolloid dressings, surgeries, drugs and skin grafts, among others [17-22], also, the therapy should be accompanied by educational health programs and changes in lifestyle. Even though, there are not enough when the problem is severe because it will progressive into amputation [23,24].

In other hand, in the last years it has been increasing the use of growth factors, 3D scaffolds and mesenchymal stem cells [25-31]-this has been called regenerative medicine (RM) [32,33]- for these wounds, where the treatment has had better healing and economical outcomes than conventional therapy [12,34]. A key factor of medicine regenerative’s development was the discovery of mesenchymal stem cells (MSC) by Friednestein et al. [35-37]. In addition to this, subsequent researches have shown the capability of the MSC to autorenew, differentiation, synthesis of extracellular matrix, intercellular signaling, modulation of immune response and not to generation of rejection like others tissues [38-40]. All these characteristics have been crucial to employ the MSC to rebuild tissues and organs [38-53].

In the research made by Benítez-Arvízu et al. [54], strategies of medicine regenerative were implemented by the use of: a) growth factors of platelets [55,56], b) 3D scaffold of skin [57], and c) mesenchymal stem cells of bone marrow [54,58] (Figure 1). This therapy was possible because other researches have demonstrated the benefit of this kind of treatment in similar wounds [12,34,59]. At the same way, after several months of treatment, they could see completely incorporation of the 3D, this without side effects were seen.

Figure 1: A schema about the implementation of medicine regenerative in the patient; firstly, there was necessary to get a skin biopsy (a), bone marrow (b), and peripheral blood (c) of the patient. After these, the elements were processed to obtain; a 3D scaffold (d), plasma rich platelet (e) and bone marrow mesenchymal stem cells (BM-MSCs) (f). As the BM-MSCs, the 3D scaffold was kept in culture conditions on Carrel’s Flask at 37°C, 5% of CO2 and saturated humidity until its use (g). Finally, in completely asepsis at operating room and previously surgical scrubbing, the 3D scaffold was fixed by suture at wound area (i) and the BM-MSCs into the PRP were placed (j).

In many researches have been demonstrated that medicine regenerative strategies in patients were best than conventional therapies, without collateral effects have been seen [30,60-65]. This becomes to RM an important element of support to the treatment in the case of cutaneous wounds with small possibilities of healing [66,67]. It is important to highlight that a good handling of DFUs could avoid more than half of amputations and, of course, this could represented a great save of money and improvements of patients quality life [68-73].


Even though, there are a lot of information about the mesenchymal stem cells biology, there is still very limit the knowledge of the regenerative mechanisms induced by them in patients [74-77]. However, the increasing of clinic trials based in MSC could let us understand better the effect of them in vivo and this will open new scenes to strengthen and valid clinic trials of medicine regenerative a great scale [65,78-81]. This could be a solution by the world health problems that DM2, its complications and other kinds or disease do [82]. Finally, although our expectations about what medicine regenerative can do are huge, there are still a lot of things to do.


The authors thank to the Lizbeth G. Diaz-Garcia engineer by the support on figures development. In addition, the researcher H. Diaz- Garcia would like to thank to the Consejo Nacional de Ciencia y Tecnologia of Mexico (CONACyT) by economical support.


Citation: Diaz-Garcia H, Benítez-Arvízu G (2016) Transcendence of Medicine Regenerative Strategies in the Treatment for Diabetic Foot Ulcers. J Cancer Diagn 1:106. Doi: 10.4172/2476-2253.1000106

Copyright: © 2016 Diaz-Garcia H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 2230
  • [From(publication date): 0-2016 - Nov 28, 2021]
  • Breakdown by view type
  • HTML page views: 1903
  • PDF downloads: 327
Share This Article